Software As A Medical Device (SaMD) Market Projected at $84269.39 Billion by 2029 | Strategic Insights and Forecast Data
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has the Software As A Medical Device (SaMD) Market Size Changed, over the years?
In recent times, the Software as a Medical Device (SaMD) market has witnessed considerable expansion. The market, assessed at $29802.38 billion in 2024, is projected to escalate to $36884.09 billion in 2025, implying a Compound Annual Growth Rate (CAGR) of 23.8%. The significant growth throughout the previous period can be traced back to factors such as globalization, increasing multifaceted challenges, fluid market trends, collaborative efforts in research and development, and objectives centered on sustainability.
How Much Will the Software As A Medical Device (SaMD) Market Be Worth in 2029?
The SaMD market is projected to experience massive expansion in the coming years, with its valuation reaching $84269.39 billion in 2029, reflecting a CAGR of 22.9%. This anticipated growth over the forecasting period is linked to a range of factors including regulatory shifts, increased focus on cybersecurity, application of AI and data analytics, the worldwide health emergency response, and the use of blockchain for instilling trust and ensuring transparency. Key emerging trends over the forecast period comprise ecosystem collaborations, fast-paced tech obsoletion, digital metamorphosis, exploration of novel technologies, a must for innovation, and progressive tech advancements.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12446&type=smp
Which is the Largest Company in the Software As A Medical Device (SaMD) Market?
Major companies operating in the software as a medical device (SaMD) market include Apple Inc., McKesson Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthcare GmbH, GE HealthCare Technologies Inc., Roche Diagnostics, 3M Health Care, Cerner Corporation, Illumina Inc., Philips Medical Systems Ltd., Dexcom Inc., Sysmex Corporation, Carl Zeiss Meditec AG, Nihon Kohden Corporation, Zhlke Group, Viz ai Inc., Paragon Biosciences LLC, S3 Connected Health, Arterys Inc., BrightInsight Inc., Agfa HealthCare Corp., iSchemaView Inc., VitalConnect Inc., Volpara Health Technologies, Tietronix Software Inc., Velentium LLC, Greenfinch Technology Ltd., MaxQ AI Ltd., IDx Technologies Inc.
What Are the Main Market Drivers in the Software As A Medical Device (SaMD) Industry?
The growth of the software as a medical device (SaMD) market is predicted to surge due to the increasing implementation of IoT in the healthcare domain. IoT in healthcare refers to medical equipment and software that interface with Internet networks to retrieve information from healthcare IT systems. One of the prominent applications of IoT within the healthcare industry is remote patient monitoring, which leverages connected devices and sensors to oversee the health status of patients and gather data remotely. IoT-enabled telemedicine, a transformative technology, is also adopted in this industry, leading to proactive medical interventions, personalized care, better patient results, and increased privacy. For example, a study by Medicon Publications in May 2023 revealed that in 2021, 80% of Americans supported the use of remote patient monitoring, projecting that about 30 million patients in the US are estimated to utilize remote patient monitoring technologies and services by 2024. Therefore, the surging uptake of IoT in healthcare is propelling the SaMD market’s growth.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=12446&type=smp
How Is the Software As A Medical Device (SaMD) Market Segments Structured?
The software as a medical device (SaMD) market covered in this report is segmented –
1) By Device Type: Wearable Device, PCs And Laptop, Smartphone And Tablets
2) By Deployment Method: Cloud-Based, On-Premise
3) By Application: Diagnostic, Clinical Management
Subsegments:
1) By Wearable Devices: Smartwatches With Health Monitoring Functions, Fitness Trackers, Wearable ECG And Blood Pressure Monitors
2) By PCs And Laptops: Medical Diagnostic Software, Clinical Decision Support Software, Telemedicine Platforms
3) By Smartphone And Tablets: Mobile Health (mHealth) Apps, Remote Patient Monitoring Software, Diagnostic Imaging Apps
What Strategic Trends Are Transforming the Software As A Medical Device (SaMD) Market?
The surge in AI-enhanced software is a notable trend in the Software as a Medical Device (SaMD) market. Many leading corporations in the SaMD market are creating groundbreaking AI-fueled software to maintain their market share. For example, Genomic Vision., a biotech firm based in France, unveiled an AI-empowered software named FiberSmart in May 2023. This state-of-the-art software is engineered to automate the detection and measuring of fluorescent signals on combed DNA molecules. It is capable of analyzing DNA replication kinetics, which is a DNA duplication process . This technology enables DNA molecules to be neatly organized and separated, simplifying the task of detection and measurement of fluorescent signals. Moreover, it boasts AI-driven detection and measurement, a user-oriented user interface, and offers scalability and adaptability. It provides compatibility with Genomic Vision’s scanner range and has been successfully screened and authenticated.
Access The Full Report Here:
Which Global Regions Offer the Highest Growth in the Software As A Medical Device (SaMD) Market?
North America was the largest region in the software as a medical device (SaMD) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the software as a medical device (SaMD) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12446
This Report Delivers Insight On:
1. How big is the software as a medical device (samd) market, and how is it changing globally?
2. Who are the major companies in the software as a medical device (samd) market, and how are they performing?
3. What are the key opportunities and risks in the software as a medical device (samd) market right now?
4. Which products or customer segments are growing the most in the software as a medical device (samd) market?
5. What factors are helping or slowing down the growth of the software as a medical device (samd) market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.
